These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4790621)

  • 1. Cephalexin concentrations in sputum during acute respiratory infections.
    Halprin GM; McMahon SM
    Antimicrob Agents Chemother; 1973 Jun; 3(6):703-7. PubMed ID: 4790621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cephalexin in lower respiratory tract infections.
    Raff MJ
    Postgrad Med J; 1983; 59 Suppl 5():32-9. PubMed ID: 6364088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum levels and sputum levels of cefmenoxime in respiratory tract infections].
    Matsumoto Y; Ninomaru S; Koshobu T; Ishikawa J; Nakatani S; Sasaki T
    Jpn J Antibiot; 1985 Jun; 38(6):1638-42. PubMed ID: 3862881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and sputum levels of cefaclor.
    Simon C; Gatzemeier U
    Postgrad Med J; 1979; 55 Suppl 4():30-4. PubMed ID: 548940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cephalexin therapy for infections complicated by age and concurrent diseases. A study in general practice.
    Cooke DM
    Chemotherapy; 1979; 25(6):356-61. PubMed ID: 520078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies of sustained release cephalexin (S-6437) in pediatrics (author's transl)].
    Saito K; Ubukata K; Konno M
    Jpn J Antibiot; 1977 Sep; 30(9):672-6. PubMed ID: 916187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cephalexin levels in the bronchial secretion of children (author's transl)].
    Daschner F
    MMW Munch Med Wochenschr; 1977 Mar; 119(10):339-40. PubMed ID: 403412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cephalexin in the treatment of upper respiratory tract infections.
    Disney FA
    Postgrad Med J; 1983; 59 Suppl 5():28-31. PubMed ID: 6364087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the antibiotic levels in blood and in respiratory secretions in various types of bronchopulmonary infections].
    Cía P; Rubio MC; Millastre A; Pacheco G; Civeira Murillo E; Suárez Pinilla MA; Rodrigo G; Sánchez Miret JI; Calderero JL
    Rev Clin Esp; 1980 Sep; 158(6):289-95. PubMed ID: 7209022
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fundamental and clinical studies on S-6436 (author's transl)].
    Nasu M; Nakatomi M; Hirota M; Nagasawa T; Horiuchi N
    Kansenshogaku Zasshi; 1977 Jul; 51(7):371-6. PubMed ID: 411852
    [No Abstract]   [Full Text] [Related]  

  • 11. A placebo-controlled trial of cephalexin therapy in the ambulatory management of patients with cystic fibrosis.
    Loening-Baucke VA; Mischler E; Myers MG
    J Pediatr; 1979 Oct; 95(4):630-7. PubMed ID: 383934
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha 1-antichymotrypsin in infected and noninfected sputum.
    Stockley RA; Burnett D
    Am Rev Respir Dis; 1980 Jul; 122(1):81-8. PubMed ID: 6893262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of acute respiratory infections in adult patients. Determination of antibiotic levels in blood and respiratory secretions].
    Cia P; Rubio MC; Pacheco G; Millastre A; Civeira Murillo E; Suárez Pinilla MA; Calderero JL; Martin F; Rodrigo G
    Rev Clin Esp; 1980 Jan; 156(2):85-92. PubMed ID: 7367704
    [No Abstract]   [Full Text] [Related]  

  • 14. Effective monitoring of concentrations of ofloxacin in saliva of patients with chronic respiratory tract infections.
    Koizumi F; Ohnishi A; Takemura H; Okubo S; Kagami T; Tanaka T
    Antimicrob Agents Chemother; 1994 May; 38(5):1140-3. PubMed ID: 8067752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and laboratory studies on S-6437 (a new longacting granule of cephalexin) in pediatric field (author's transl)].
    Kondo K; Kuno K; Koide T; Fukaya K; Jose H
    Jpn J Antibiot; 1977 Sep; 30(9):691-8. PubMed ID: 916190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of the preparation Palitrex (cephalexin monohydrate)].
    Wojtacha-Wencel B; Urbańska D; Wojnar J
    Wiad Lek; 1982 Jun; 35(6):385-90. PubMed ID: 7123926
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serum and sputum levels of cefotetan used in respiratory tract infections].
    Matsumoto Y; Hitsuda Y; Sugimoto Y; Ishikawa J; Sasaki T
    Jpn J Antibiot; 1986 Oct; 39(10):2690-4. PubMed ID: 3468274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties.
    Speight TM; Brogden RN; Avery GS
    Drugs; 1972; 3(1):9-78. PubMed ID: 4559812
    [No Abstract]   [Full Text] [Related]  

  • 19. The secretion of minocycline in sputum during therapy of bronchopulmonary infection in chronic chest diseases.
    Brogan TD; Neale L; Ryley HC; Davies BH; Charles J
    J Antimicrob Chemother; 1977 May; 3(3):247-51. PubMed ID: 873874
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of cepharadine and cephalexin in the treatment of respiratory and urinary tract infections.
    Mogabgab WJ
    Curr Ther Res Clin Exp; 1976 Apr; 19(4):421-32. PubMed ID: 4284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.